右美托咪定复合瑞芬太尼在无痛ERCP中的临床观察(1)
[摘要] 目的 探讨右美托咪定复合瑞芬太尼在ERCP中的有效性及安全性。方法 方便选择拟行ERCP术的患者62例，将其按照麻醉方法分为A组和B组，A组给予右美托咪定复合瑞芬太尼麻醉，B组患者给予丙泊酚复合瑞芬太尼麻醉，分别记录2组患者个各时段血压、HR、呼吸频率(RR)等相关指标。 结果 手术开始后，B组患者在各时间点的SBP、DBP和HR均明显高于A组 (P<0.05)；两组患者呼吸频率在插镜、套石、退镜各时点相比差异具有统计学意义(P<0.05)，而在睁眼时则差异不明显。A组呼吸抑制、心动过缓分别为2例、12例，对照组分别为12例、2例。 结论 右美托咪定复合瑞芬太尼可可安全有效地应用于ERCP操作。
[关键词] 右美托咪定；瑞芬太尼；ERCP
[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2016)05(a)-0131-02
[Abstract] Objective To discuss the effectiveness and safety of dexmedetomidine and remifentanil in the ERCP. Methods 62 cases of patients planning for ERCP operation were selected and divided into two groups according to different anaesthesia methods ......
您现在查看是摘要页，全文长 3476 字符。
[关键词] 右美托咪定；瑞芬太尼；ERCP
[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2016)05(a)-0131-02
[Abstract] Objective To discuss the effectiveness and safety of dexmedetomidine and remifentanil in the ERCP. Methods 62 cases of patients planning for ERCP operation were selected and divided into two groups according to different anaesthesia methods ......
您现在查看是摘要页，全文长 3476 字符。